Current concepts in peritonitis

Current Gastroenterology Reports

Volumn 5, Issue 4, 2003, Pages 295-301

  Malangoni, Mark A ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CILASTATIN; CIPROFLOXACIN; CLINDAMYCIN; ERTAPENEM; FLUCONAZOLE; IMIPENEM; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL PERITONITIS; BACTERIUM CULTURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HUMAN; INCIDENCE; INFECTION CONTROL; LAPAROTOMY; MALNUTRITION; MORTALITY; PATHOGENESIS; REVIEW; RISK FACTOR; SECOND LOOK SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME; PATHOPHYSIOLOGY; PERITONITIS;

HUMANS; PERITONITIS;

EID: 0042831262     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0066-y     Document Type: Review

References (50)

1. Malangoni MA: Evaluation and management of tertiary peritonitis. Am Surg 2000, 66:157-161.
2. Krepel CJ, Gohr CM, Edmiston CE, Condon RE: Surgical sepsis: constancy of antibiotic susceptibility of causative organisms. Surgery 1995, 117:505-509.
3. Merlino JI, Malangoni MA, Smith CM, Lange RL: Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg 2001, 233:859-866.
4. Montravers P, Gauzit R, Muller C, et al.: Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996 23:486-494.
5. Nathens AB, Rotstein OD, Marshall JC: Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998, 22:158-163.
6. Seiler CA, Brügger L, Forssmann U, et al.: Conservative surgical treatment of diffuse peritonitis. Surg 2000, 127:178-184.
7. Christou NV, Turgeon P, Wassef R, et al.: Management of intraabdominal infections: the case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996, 131:1193-1201.
8. Dunn DL, Barke RA, Knight NB, et al.: Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 1985, 49:257-264.
9. Nelson JL, Alexander JW, Mao JX, et al.: Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis. Crit Care Med 1999, 27:113-119.
10. Riche FC, Cholley BP, Panis YH, et al.: Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 2000 28:433-437.
11. Tang GJ, Huang SL, Yien HW, et al.: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736.
12. O'Keefe GE Hybki DL Munford RS: The G → A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002, 52:817-825.
13. vanSonnenberg E, Wittich GR, Goodacre BW, et al.: Percutaneous abscess drainage: update. World J Surg 2001, 25:362-369.
14. Malangoni MA, Shumate CR, Thomas HA, Richardson JD: Factors influencing the treatment of intra-abdominal abscesses. Am J Surg 1990, 159:167-171.
15. Cinat ME, Wilson SE, Din AM: Determinants for successful percutaneous image-guided drainage of intraabdominal abscess. Arch Surg 2002, 137:845-849.
16. Baril NB, Ralls PW, Wren SM, et al.: Does an infected peripancreatic fluid collection or abscess mandate operation? Ann Surg 2000, 231:361-367.
17. Stabile BE, Puccio E, vanSonnenberg E, Neff C: Preoperative percutaneous drainage of diverticular abscesses. Am J Surg 1990, 159:99-104.
18. Haaga JR, Nakamoto D, Stellato T, et al.: Intracavitary urokinase for enhancement of percutaneous abscess drainage: phase II trial. AJR Am J Roentgenol 2000, 174:1681-1685.
19. Kok KY, Yapp SK: Laparoscopic drainage of postoperative complicated intraabdominal abscesses. Surg Laparosc Endosc Percutan Tech 2003, 10:311-313.
20. Butler JA, Huang J, Wilson SE: Repeated laparotomy and postoperative intra-abdominal sepsis: an analysis of outcome predictors. Arch Surg 1987, 122:702-706.
21. Wacha H, Hau T, Dittmer R, Ohmann C: Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 1999, 384:24-32.
22. Koperna T, Schulz F: Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000 24:32-37.
23. Solomkin JS, Wilson SE, Christou NV, et al.: Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 2001, 233:79-87.
24. Wilson SE, Faulkner K, Biol C, Biol MI: Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 1998, 64:402-407.
25. Solomkin JS, Yellin AE, Rotstein OD, et al., and the Protocol 017 Study Group: Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 2003, 237:235-245.
26. Cohn SM, Lipsett PA, Buchman TG, et al.: Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of intraabdominal infections. Ann Surg 2000 232:254-262.
27. Bosscha K, Reijnders K, Hulstaert PF, et al.: Prognostic scoring systems to predict outcome in peritonitis and intraabdominal sepsis. Br J Surg 1997, 84:1532-1534.
28. Christou NV, Barie PS, Dellinger EP, et al.: Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 1993, 128:193-198.
29. Evans HL, Raymond DP, Pelletier SJ, et al.: Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect 2001, 2:255-265.
30. Pusajo JF, Bumaschny E, Doglio GR, et al.: Postoperative intraabdominal sepsis requiring reoperation: value of a predictive index. Arch Surg 1993, 128:218-222.
31. Billing A, Fröhlich D, Schildberg FW, and the Peritonitis Study Group: Prediction of outcome using the Mannheim Peritonitis Index in 2003 patients. Br J Surg 1994, 81:209-213.
32. Wickel DJ, Cheadle WG, Mercer-Jones MA, Garrison RN: Poor outcome from peritonitis is caused by disease acuity and organ failure not recurrent peritoneal infection. Ann Surg 1997, 225:744-756.
33. Khuri SF, Daley J, Henderson W, et al.: Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997, 185:316-327.
34. Kollef MH: Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131-S138.
35. Malangoni MA, Condon RE, Spiegel CA: Treatment of intraabdominal infections is appropriate with single agent or combination antibiotic therapy. Surg 1985, 98:648-655.
36. Sandven P, Qvist H, Skovlund E, Giercksky KE, for the NORGAS group and the Norwegian Yeast Study Group: Significance of Candida recovered from intraoperative specimens in patients with intraabdominal perforations. Crit Care Med 2002, 30:541-547.
37. Gloor B, Worni M, Büchler MW: Diffuse peritonitis. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:87-91.
38. Schein M, Marshall JC, eds: Source Control: A Guide to the Management of Surgical Infections. Berlin: Springer; 2003.
39. Sawyer RG: Tertiary peritonitis. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:341-347.
40. Hau T, Ohmann C, Wolmershauser A, et al.: Planned relaparotomy vs relaparotomy on demand in the treatment of intraabdominal infections. The Peritonitis Study Group of the Surgical Infection Society-Europe. Arch Surg 1995, 130:1193-1196.
41. Hinsdale JG, Jaffe BM: Re-operation for intra-abdominal sepsis: indications and results in modern critical care setting. Ann Surg 1984, 199:31-36.
42. Steinberg D: On leaving the peritoneal cavity open in acute generalized suppurative peritonitis. Am J Surg 1979, 1376:216-220.
43. Schein M, Paladugtu R: Planned relaparotomies and laparostomy. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:412-423.
44. Platell C, Papadimitriou JM, Hall JC: The influence of lavage on peritonitis. J Am Coll Surg 2000, 191:672-680.
45. Mazuski JE, Sawyer RG, Nathens AB, et al.: The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: an executive summary. Surg Infect 2002, 3:161-173.
46. Bailey JA, Virgo KS, DiPiro JT, et al.: Aminoglycosides for intraabdominal infection: equal to the challenge? Surg Infect 2002, 3:315-335.
47. Taylor E, Dev V, Shah D, et al.: Complicated appendicitis: is there a minimum intravenous antibiotic requirement? A prospective randomized trial. Am Surg 2000, 66:887-890.
48. Barie PS, Christou NV, Dellinger EP, et al.: Pathogenicity of the enterococcus in surgical infections. Ann Surg 1990, 212:155-159.
49. Burnett RJ, Haverstock DC, Dellinger EP, et al.: Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 1995, 118:716-721.
50. Scheingraber S, Kurz T, Dralle H: Short- and long-term outcome and health-related quality of life after severe peritonitis. World J Surg 2002, 26:667-671.